终末期肾病患者自然调节性T细胞可用于大规模制备高抑制性同种抗原特异性调节性T细胞
研究比较终末期肾病(ESRD)患者(透析或未透析)与年龄性别匹配健康人的自然调节性T细胞(nTreg),经同种异体成熟单核细胞衍生树突状细胞联合抗CD3/抗CD28包被磁珠扩增后,nTreg频率、表型、FOXP3基因Treg特异性去甲基化区域(TSDR)去甲基化状态、抑制能力和细胞因子谱均相似,患者nTreg可有效扩增为稳定的同种抗原特异性nTreg。
要点
- ESRD患者循环nTreg频率与年龄性别匹配健康人相似,透析与否无差异。
- 患者nTreg经同种异体成熟树突状细胞联合磁珠扩增效果等同或更优。
- 扩增后TSDR去甲基化状态维持或促进,表型、抑制能力和细胞因子谱与健康人相似。
核心结论
- ESRD患者循环nTreg可有效扩增为稳定的同种抗原特异性nTreg,具有潜在临床适用性。
研究设计与样本
- 研究比较ESRD患者(透析或未透析)与年龄性别匹配健康个体的循环nTreg,经同种异体成熟单核细胞衍生树突状细胞联合抗CD3/抗CD28包被磁珠扩增,并分析TSDR去甲基化状态、nTreg标志物表达、抑制能力和细胞因子产生细胞。
主要发现
- 与年龄性别匹配健康人相比,ESRD患者(透析或未透析)循环nTreg频率相似。
- 分离的nTreg经同种异体成熟单核细胞衍生树突状细胞扩增效果等同或更优,广泛表征未显示显著差异。
- TSDR去甲基化状态维持或进一步促进,nTreg特征性标志物表达亦如此。
- 同种异体成熟单核细胞衍生树突状细胞扩增的nTreg抑制能力和细胞因子谱与健康人相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Natural occurring regulatory T cells (nTregs) have the potential to offer a targeted approach of immunosuppression and are the cell type of interest for inducing tolerance in kidney transplantation. End-stage renal disease (ESRD) profoundly affects the composition and function of circulating T cells but little is known with respect to how nTreg potential is affected. To address this, nTregs of patients with ESRD (on dialysis or not) and healthy individuals were isolated, expanded using allogeneic mature monocyte-derived dendritic cells followed by anti-CD3/anti-CD28-coated beads and the different nTregs were extensively characterized by the demethylation status of the Treg-specific demethylated region within FOXP3 and expression of typical nTreg markers. Additionally, the suppressive capacity as well as cytokine producing cells were analyzed for allogeneic mature monocyte-derived dendritic cell-expanded nTregs. Compared to age- and gender-matched healthy individuals, similar frequencies of nTregs were present within the circulation of patients with ESRD either on dialysis or not. The isolated nTregs could be equally well or even better expanded using allogeneic mature monocyte-derived dendritic cells and extensive characterization did not reveal significant differences. The demethylation status of the Treg-specific demethylated region was maintained or even further promoted as was the expression of markers characteristic for nTregs. Moreover, suppressive capacity and the cytokine profile of allogeneic mature monocyte-derived dendritic cell-expanded nTregs was similar to that of healthy individuals. Thus, circulating nTregs of patients with ESRD can effectively be expanded to stable allo antigen-specific nTregs with potential clinical applicability.
引用
- Litjens NH, Boer K, Zuijderwijk JM, et al. Natural regulatory T cells from patients with end-stage renal disease can be used for large-scale generation of highly suppressive alloantigen-specific Tregs. Kidney Int. 2016. PMID: 27988212. doi:10.1016/j.kint.2016.09.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。